Matinas BioPharma Holdings Inc./$MTNB
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Matinas BioPharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
Ticker
$MTNB
Sector
Primary listing
AMEX
Industry
Biotechnology
Headquarters
Employees
3
ISIN
US5768103039
Website
MTNB Metrics
BasicAdvanced
$4.7M
-
-$3.98
1.30
-
Price and volume
Market cap
$4.7M
Beta
1.3
52-week high
$1.19
52-week low
$0.47
Average daily volume
405K
Financial strength
Current ratio
3.347
Quick ratio
3.071
Long term debt to equity
30.622
Total debt to equity
43.285
Interest coverage (TTM)
-16,206.00%
Profitability
EBITDA (TTM)
-15.912
Effective tax rate (TTM)
0.40%
Management effectiveness
Return on assets (TTM)
-64.01%
Return on equity (TTM)
-192.85%
Valuation
Price to book
0.74
Price to tangible book (TTM)
0.74
Price to free cash flow (TTM)
-0.382
Free cash flow yield (TTM)
-261.69%
Free cash flow per share (TTM)
-240.02%
Growth
Earnings per share change (TTM)
-25.69%
3-year earnings per share growth (CAGR)
-11.51%
10-year earnings per share growth (CAGR)
-13.08%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Matinas BioPharma Holdings Inc. stock?
Matinas BioPharma Holdings Inc. (MTNB) has a market cap of $4.7M as of July 04, 2025.
What is the P/E ratio for Matinas BioPharma Holdings Inc. stock?
The price to earnings (P/E) ratio for Matinas BioPharma Holdings Inc. (MTNB) stock is 0 as of July 04, 2025.
Does Matinas BioPharma Holdings Inc. stock pay dividends?
No, Matinas BioPharma Holdings Inc. (MTNB) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Matinas BioPharma Holdings Inc. dividend payment date?
Matinas BioPharma Holdings Inc. (MTNB) stock does not pay dividends to its shareholders.
What is the beta indicator for Matinas BioPharma Holdings Inc.?
Matinas BioPharma Holdings Inc. (MTNB) has a beta rating of 1.3. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.